Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study's history shows the recruitment status changed to no longer looking for participants, signaling that enrollment has ended. The record version advanced to v3.6.0, superseding the previous v3.5.5 entry.SummaryDifference0.3%

- Check20 days agoChange DetectedA new latest revision entry (v3.5.5) is added to the record history, replacing the previous revision (v3.5.4). This indicates a minor administrative update to the page rather than substantive changes to the study record.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry v3.5.4 was added to the study's record history, and the previous entry v3.5.3 was removed, reflecting an update to the page's history metadata.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s displayed software/version label has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site update rather than a change to the trial record itself.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed from the study record history.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.SummaryDifference0.1%

Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.